A simple outpatient procedure may provide a majority of people who discontinue popular weight-loss drugs a way to prevent regaining their lost pounds, scientists reveal in a new study.
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have ushered in a new era of diabetes management and weight loss, with some estimates suggesting 1 in 8 Americans could be taking these jabs.